礼来(Eli Lilly)盘前股价上涨2.3%,其GLP-1口服药物在后期试验中令2型糖尿病患者体重减轻10.5%

美股速递
Aug 26, 2025

礼来(Eli Lilly)股价在盘前交易中上涨2.3%,此前该公司宣布其GLP-1口服药物在后期临床试验中成功帮助2型糖尿病患者减重10.5%。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10